INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON
Disc Medicine, Inc. (IRON)
Company Research
Source: GlobeNewswire
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Disc Medicine, Inc. (“Disc” or the “Company”) (NASDAQ: IRON). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Disc and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On January 15, 2026, Reuters reported that a drug under development by Disc faced a delay in its review timeline “after [U.S. Food and Drug Administration] scientists flagged safety and efficacy concerns[.]” On this news, Disc’s stock price fell $6.04 per share, or 7.84%, to close at $71.04 per share on January 15, 2026. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities,
Show less
Read more
Impact Snapshot
Event Time:
IRON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRON alerts
High impacting Disc Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
IRON
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRONPR Newswire
- Disc Medicine (NASDAQ:IRON) had its "overweight" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Disc Medicine (NASDAQ:IRON) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- Disc Medicine (NASDAQ:IRON) had its "outperform" rating reaffirmed by analysts at Wedbush.MarketBeat
- Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer [Yahoo! Finance]Yahoo! Finance
IRON
Earnings
- 11/6/25 - Miss
IRON
Sec Filings
- 1/21/26 - Form 4
- 1/12/26 - Form 8-K
- 1/7/26 - Form SCHEDULE
- IRON's page on the SEC website